HRT Financial’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-29,840
Closed -$1.53M 3658
2025
Q2
$1.53M Buy
+29,840
New +$1.5M 0.01% 1055
2024
Q3
Sell
-107,107
Closed -$7.67M 3121
2024
Q2
$7.67M Buy
107,107
+101,362
+1,764% +$7.46M 0.04% 288
2024
Q1
$404K Buy
5,745
+1,881
+49% +$135K ﹤0.01% 1375
2023
Q4
$298K Buy
+3,864
New +$255K ﹤0.01% 1625
2022
Q4
Sell
-25,972
Closed -$1.84M 3134
2022
Q3
$1.84M Sell
25,972
-612
-2% -$52.9K 0.02% 635
2022
Q2
$2.3M Buy
+26,584
New +$2.49M 0.03% 515
2021
Q2
Sell
-93,220
Closed -$8.9M 3518
2021
Q1
$8.9M Buy
93,220
+21,864
+31% +$1.99M 0.09% 147
2020
Q4
$5.66M Sell
71,356
-77,640
-52% -$5.62M 0.11% 142
2020
Q3
$9.23M Buy
+148,996
New +$9.69M 0.27% 65
2020
Q1
Sell
-6,552
Closed -$359K 1324
2019
Q4
$359K Sell
6,552
-33,124
-83% -$1.74M 0.02% 668
2019
Q3
$1.94M Buy
+39,676
New +$1.99M 0.09% 177

Other funds holding TECH

HRT Financial's TECH Position: Q3 2025 in Review

HRT Financial sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 29,840 shares — an estimated $1.53M sold.

HRT Financial first reported a position in TECH in Q3 2019 and held it in 11 quarters. The position peaked at $9.23M in Q3 2020. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • HRT Financial reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 29,840 Bio-Techne shares in Q3 2025, an estimated $1.53M.
  • HRT Financial first reported a position in Bio-Techne in Q3 2019 and held it in 11 quarters.
  • HRT Financial's Bio-Techne position peaked at $9.23M in Q3 2020.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.